Permethrin-treated mosquito nets and the EU BPR regulatory calendar: what 2026-2028 means for the treated-article category

If you are a European buyer trying to understand what is happening with permethrin-treated mosquito nets under EU rules, this article sets out the calendar. It answers the questions buyers ask most: whether the category is being phased out, whether authorisations are about to lapse, and whether "candidate for substitution" means a product recall. It also explains how the Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) treats the permethrin-treated article family, and how the EU and WHO tracks relate to each other.

This article covers permethrin-treated nets only. Untreated nets and other physical barriers are not biocidal products, and the BPR does not regulate them. None of the BPR claims or calendar entries below apply to them. Every statement about permethrin, EU BPR authorisation or WHO prequalification is scoped to permethrin-treated articles.

This is a standing reference. It is published so that the dates and the regulator language stay stable and verifiable. It is republished at each material change.

What this article is, and what it is not

This article is a regulatory calendar for permethrin-treated mosquito nets under the EU BPR. It records the product authorisation in force, the active-substance review window that surrounds it, and the BPR events the 2026-2028 window contains.

This article is not a medical claim, an efficacy comparison with repellent alternatives, or a regulatory guarantee. No GOTS or OEKO-TEX claim is made or implied in relation to any treated net or any untreated barrier. No partnership or endorsement by any research institute is claimed. Untreated physical barriers are outside the scope of the BPR and are not addressed in this piece.

The headline facts about permethrin-treated nets

The article-58 family structure is documented in the EU BPR register and in the product authorisation record. The key dates in this article come from the BPR text, the ECHA register and the published Commission documents listed in the Sources.

Those three facts, the active substance, the product type and the authorisation route, decide which BPR clocks apply to a treated net and which do not. The active substance and the product type are the same across the category. The authorisation route is the same for every treated article placed on the EU market.

How to read the BPR in this product context

The BPR is the EU regulation that governs biocidal products and the active substances they contain. Two of its 22 defined product types are relevant to mosquito control:

• PT18: insecticides, acaricides and products to control other arthropods. Treated mosquito nets fall here. A mosquito that contacts the treated surface dies. The active substance (permethrin) must be approved at EU level, and the finished product must be authorised under Article 58 of the BPR (treated articles) or under a national Union authorisation.
• PT19: repellents and attractants. Skin-applied repellents fall here. They do not apply to treated nets.

The BPR runs on three separate clocks that operate at different layers and that are often confused in consumer coverage:

1. The active-substance clock. The EU-level approval of permethrin as an active substance for PT18. This is the rolling 2026-2027 pyrethroid review programme at ECHA. The non-approval extension for permethrin runs through October 2028.
2. The product authorisation clock. The product authorisation that covers treated articles. It is valid through 2032.
3. The treated-article clock. Article 58 requires the treated article's label and Summary of Product Characteristics (SPC) to match the authorised wording. Label deviation is an immediate market-surveillance risk and operates continuously; it is not a calendar event.

The three clocks intersect. If the active-substance clock fails (permethrin approval lapses or is not renewed at EU level), all permethrin products lose EU market access. If the product authorisation clock fails (the 2032 renewal is mishandled), the authorised products lose EU market access. If the treated-article clock fails (the label drifts away from the SPC), a market-surveillance finding can withdraw product from sale irrespective of the other two clocks.

The standing position is that all three clocks are tracked, and that the Article 58 label is the most immediate compliance requirement for the 2026-2027 window.

For a buyer, the practical reading is simple. The category is not being phased out. The active-substance review is the layer to watch, because it is external to any single product. The label requirement is the layer that applies continuously.

The 2026-2028 calendar for the treated permethrin family

The table below lists the BPR events tracked for the treated category. It is the operational calendar that drives the regulatory watch for treated nets. Items marked watching are external events; items marked planned are steps an authorisation holder takes; items marked regulator action are ECHA-, BPC- or Commission-led.

The standing position is that the 2026-2028 window is calm for the treated category, with the active-substance review programme being the main external variable. The renewal procedure does not begin until late 2027 or early 2028, and the substantive dossier is not due until early 2030. There is no near-term expiry, no phase-out, and no in-force market-withdrawal action affecting permethrin-treated articles.

What "Candidate for Substitution" means, and what it does not mean

Permethrin appears on ECHA's list of Candidates for Substitution under BPR Article 10(1). The label is regulator language and has a specific technical meaning:

• What it is. Article 10(1) flags active substances that meet certain criteria, for example substances that are persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB), or that have other intrinsic properties of concern at EU level. The flag is a procedural note attached to the substance's approval conditions; it is not a recall, a phase-out, or a market action.
• What it triggers. When a product containing a Candidate-for-Substitution active substance comes up for authorisation or renewal, the evaluating competent authority performs a comparative assessment and considers whether the product can be replaced by an already-authorised product or a non-chemical alternative. The substitution analysis is part of the normal authorisation process, not an ad-hoc withdrawal.
• What it does not trigger. Candidate-for-Substitution status does not require existing products to be withdrawn, does not shorten the validity of an existing product authorisation, and does not override a Member State or Union-level authorisation that is already in force. The authorisation in force runs through 2032 on its published terms, with the Candidate-for-Substitution flag tracked inside the renewal evaluation when it occurs.
• What the consumer-facing consequence is. None, in the short term. The product label, the user instructions, and the protective function of the net are unchanged. The flag becomes relevant when the renewal evaluation runs in 2027-2028, and it will be reported in the renewal update published in this article at that time.

The Candidate-for-Substitution flag is part of the public record for permethrin and is not specific to any one supplier. It applies to the active substance and to every product containing it on the EU market.

For permethrin-treated nets, the flag changes no current obligation. It matters at the next renewal, when the comparative assessment is carried out under the normal BPR process. Until then, the label and the authorisation record stand as published.

What WHO prequalification means for treated nets, and how to read the label

The World Health Organization Prequalification Programme for Vector Control Products evaluates long-lasting insecticidal nets (LLINs), indoor residual sprays, and similar vector-control products against WHO specifications. WHO prequalification is a separate regulatory track from EU BPR. A product can be WHO-prequalified without being BPR-authorised, and BPR-authorised without being WHO-prequalified.

Permethrin-treated articles on the EU market are:

• EU BPR authorised under the BPR (PT18, Article 58 treated article). This is the EU regulatory record.
• Built to WHO vector-control product specifications (LLIN standard, 9 g/kg factory impregnation). This is an engineering compliance statement: the construction of the net follows the WHO specification, not an efficacy claim of WHO prequalification.
• Not necessarily WHO-prequalified. A WHO Prequalification Programme listing is separate from the EU BPR authorisation. Where copy refers to WHO standards, it means the WHO specification was the engineering reference, not that the product is on the WHO prequalification list.

The distinction is one of wording, not technical: a buyer reading a product page should understand that "built to WHO standards" and "WHO prequalified" are not the same statement. The first is an engineering reference; the second is a regulator listing. This article uses the first and not the second.

Both tracks matter to a buyer, but they answer different questions. The BPR record is the EU permission to place the product on the market. The WHO specification is the engineering standard for the net itself.

The same distinction applies to the ECHA register. "EU BPR authorised" means the product appears in ECHA's R4BP 3 register under the authorisation number. It does not mean "endorsed by ECHA" or "approved by ECHA as a product", and those formulations are not used here.

What the buyer should take from this article

Three operational takeaways:

1. The treated-article product authorisation this calendar tracks is current and runs through 2032. There is no in-force market action affecting them, no current withdrawal, and no near-term expiry.
2. The active-substance layer is the standing watch. Permethrin is in ECHA's rolling 2026-2027 pyrethroid review programme; the current non-approval extension runs to October 2028. The renewal outcome affects every permethrin PT18 product on the EU market, not just treated nets, and the calendar reflects that external dependency.
3. The treated-article label is the most immediate requirement. The label and the SPC must match the authorised wording, and this is checked on an ongoing basis. Drift away from the SPC is the failure mode that produces a market-surveillance finding irrespective of the other two clocks. Buyer-facing copy is held to that SPC.

None of the three layers turns on the name of a supplier. They follow the active substance and the authorisation record.

A standing note: untreated physical barriers are not addressed by this article. They are physical barriers, not biocidal products. EU BPR authorisation, permethrin, WHO prequalification, and the ECHA pyrethroid review programme do not apply to them. No GOTS or OEKO-TEX certification is claimed for treated nets or for untreated barriers. No partnership or endorsement by any research institute is claimed.

When this article will be updated

The standing rule is that this article is republished at each of the following triggers:

• ECHA BPC opinion or decision on the permethrin PT18 review programme.
• Commission Implementing Act or SCBP vote touching permethrin, treated articles, or PT18.
• Material change to the treated-article authorisation: renewal procedure start, dossier filing, or expiry update.
• Material change to the Candidate-for-Substitution status for permethrin under BPR Article 10(1).
• Material change to the WHO Prequalification Programme listing for permethrin-treated nets.
• Material change to any BPR-related, WHO-related, or permethrin-related claim on a treated-net product page.

Updates are announced when the reference is republished. This article is the reference for the treated-article calendar across European markets.

Sources

• European Chemicals Agency (ECHA). Biocidal Products Regulation portal and R4BP 3 register. Treated-article family under Article 58 (PT18).
• European Commission. Regulation (EU) No 528/2012, Biocidal Products Regulation (BPR). Articles 10, 17, 58, 69 and 72 cited in the body.
• European Commission. Commission proposal of 16 December 2025 amending BPR to extend data protection periods until 31 December 2030. Sent to the European Parliament and Council.
• European Chemicals Agency. Biocidal Products Committee (BPC) opinion register. Pyrethroid PT18 review programme, 2026-2027 review round.
• European Chemicals Agency. Candidates for Substitution under BPR Article 10(1). Current permethrin entry.
• World Health Organization. Vector Control Product Prequalification Programme. LLIN specifications referenced.

Filed by Mosticare Editorial. Untreated physical barriers are out of BPR scope and are not addressed by this article. Standing reference; republished at material change.